Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Wafik El-Deiry
Brown University, Department: Pathology
Should you be removed from our database? Contact us at [email protected]. Read more below.
Oncoceutics, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see attached FCOI report for details.
ONC201/TIC10 Anti-tumor Effect Through Regulation of the TRAIL pathway
PROJECT NARRATIVE This research program is directed towards the highly significant problem of drug resistance in advanced cancer that may be addressed by targeting anti-tumor cell death signaling pathways. The proposal builds on discovery in the El-Deiry Lab of a new drug ONC201 targeting the TRAIL death receptor pathway that has been brought into multiple clinical trials and is showing promising activity in multiple tumor types including prostate cancer, GBM, uterine cancer, lymphoma, leukemia and colorectal cancer. The proposal provides unique and novel mechanistic insights regarding signaling within tumor cells including immune stimulation by ONC201, involvement of dopamine receptors, and explores drug resistance mechanisms.
Filed on May 06, 2019.
Tell us what you know about Wafik El-Deiry's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Wafik El-Deiry filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Wafik El-Deiry | Research Inst of Fox Chase Can Ctr | Conflict of Interest | Research Institute of Fox Chase Cancer Center | Value cannot be readily determined |
| Wafik El-Deiry | Research Inst of Fox Chase Can Ctr | Conflict of Interest | Research Institute of Fox Chase Cancer Center | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.